The increase in the number of cancer patients across the world and the rising awareness among people regarding cancer and its treatment are some of the primary factors which has assisted in the growth of the market.
As per the data provided by the American Brain Tumor Association, over four hundred patients, mainly children, are diagnosed with medulloblastoma every year, with males being more prone to the disease than women. It is the most found malignant brain tumor in children of age four and younger and the second most in children between the age range of five to fourteen years. The report further states that over one-fourth of all the adults diagnosed with medulloblastoma in the United States are of the age twenty to forty-four years. These factors are responsible for increase of the medulloblastoma market share of the United States.